MIRA INFORM REPORT

 

 

Report Date :           

14.10.2011

 

IDENTIFICATION DETAILS

 

Name :

COMPANY OF PHARMACEUTICAL PRODUCTS OF VIETNAM 

 

 

Registered Office :

 126A Tran Quoc Thao - Ward No.7 - 3 District - Ho Chi Minh City

 

 

Country :

Vietnam

 

 

Financials (as on) :

31.12.2010

 

 

Year of Establishment :

1990

 

 

Com. Reg. No.:

059018

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Import – Export, Distribution and Production of final pharmaceutical product (modern and traditional medicine), reagents and laboratory equipment

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct 

 

 

Litigation :

Clear

 


NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30th, 2011

 

Country Name

Previous Rating

                   (30.06.2011)                  

Current Rating

(30.09.2011)

Vietnam

b1

b1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

SUBJECT IDENTIFICATION & LEGAL FORM

 

Current legal status

English Name

 

COMPANY OF PHARMACEUTICAL PRODUCTS OF VIETNAM

Vietnamese Name

 

CONG TY CO PHAN Y DUOC PHAM VIETNAM

Trade name

 

CPV

Short name

 

COMPTOIR PHARMACEUTIQUE DU VIETNAM

Type of Business

 

Joint stock company

Year Established

 

1990

Establishment Decision

 

309/ QD-UB

Date of Issuance

 

27 Jun 1992

Place of Issuance

 

Hochiminh People’s Committee

Business Registration No.

 

059018

Date of Registration

 

29 Jun 1992

Place of Registration

 

Business Registration Office of Ho Chi Minh city

Current registered capital

 

3,800,000,000 VND

Tax code

 

0300479506

Total Employees

 

50

 

Historical Identification & Legal form

List

Changed Items

1

Subject has got former Registered English Name: VIETNAM PHARMACEUTICAL PRODUCTS ENTERPRISE Changed to: COMPANY OF PHARMACEUTICAL PRODUCTS OF VIETNAM

2

Subject has got former Type of Business: State Owned Enterprises

Changed to: Joint Stock Company

 

 

 

company ADDRESSES

 

 

Head Office

Address

 

126A Tran Quoc Thao - Ward No.7 - 3 District - Ho Chi Minh City - Vietnam

Telephone

 

(84-8) 3931 6263 - 3843 9694

Fax

 

(84-8) 3931 6421

Email

 

cpvnet@spymac.com

 

Other

Address

 

45A-45B Group 2- Phuoc Long B Ward - 9 District - Ho Chi Minh City - Vietnam

Business Registration No.

 

03003099CN41

Date of Registration

 

12 Feb 2001

Place of Registration

 

Business Registration Office of Ho Chi Minh city

 

 

DIRECTORS

 

 

1. NAME

 

Mr. NGUYEN DUY CUONG

Position

 

Chairman cum General Director

Date of Birth

 

27 Feb 1925

Nationality

 

Vietnamese

Qualification

 

Ph. D (Professor)

 

2. NAME

 

Ms. NGUYEN THI QUYEN

Position

 

Managing Director

Date of Birth

 

07 Dec 1940

ID Number/Passport

 

020089128

Resident

 

447 Le Quang Dinh - Ward 5 - Binh Thanh District - Ho Chi Minh City - Vietnam

Nationality

 

Vietnamese

 

3. NAME

 

Ms. HO THI NGOC HUONG

Position

 

Chief Accountant

Date of Birth

 

1960

Resident

 

Ho Chi Minh City - Vietnam

Nationality

 

Vietnamese

 


BUSINESS NATURE AND ACTIVITIES

 

• Import – export, distribution and production of final pharmaceutical product (modern and traditional medicine), reagents and laboratory equipment. Trading by selling both wholesale and retail many kinds of medicines, equipments and chemical materials.
• Currently, the subject is distributing products of Sanofi – Aventis.
• Trading milk and nutritious foodstuffs, tourist services and foreign exchange services.
• Trading medical equipment, medicinal plants and essentials oils and other products in medico – pharmaceutical field.

 

 

 

IMPORT & EXPORT ACTIVITIES

 

IMPORT:

·         Types of products

 

pharmaceutical products and material, chemicals, equipment for pharmacy

·         Market

 

France, Germany, Korea, Taiwan, China, America, England

 

EXPORT:

·         Types of products

 

essential oil

·         Market

 

France, North America, Laos, and Cambodia…

 

 

 

BANKERS

 

VIETNAM EXPORT IMPORT COMMERCIAL JOINT STOCK BANK

Address

 

No. 7 Le Thi Hong Gam Street, Nguyen Thai Binh Ward - 1 District - Ho Chi Minh City - Vietnam

Telephone

 

(84-8) 3821 0055

Fax

 

(84-8) 3829 6063

 

 

 

SHAREHOLDERS

 

1. NAME

 

Mr. NGUYEN DUY CUONG

Date of Birth

 

07 Dec 1940

Resident

 

447 Le Quang Dinh - Ward 5 - Binh Thanh District - Ho Chi Minh City - Vietnam

Nationality

 

VIET NAM

Percentage

 

0.526%

 

2. NAME

 

Ms. DUONG THANH CANH

Date of Birth

 

1932

Resident

 

63 Hai Thuong Lan Ong - 5 District - Ho Chi Minh City - Vietnam

Nationality

 

VIET NAM

Percentage

 

5.263%

 

3. NAME

 

Ms. NGUYEN THI MINH LUAN

Resident

 

446/4 Le Quang Dinh - Binh Thanh District - Ho Chi Minh City - Vietnam

Nationality

 

VIET NAM

Percentage

 

5.263%

 

4. NAME

 

Ms. NGUYEN VAN EN

Date of Birth

 

1923

Resident

 

185 Xo Viet Nghe Tinh - 1 District - Ho Chi Minh City - Vietnam

Nationality

 

VIET NAM

Percentage

 

5.263%

 

5. NAME

 

Mr. HOANG CONG KHANH

Date of Birth

 

1929

Resident

 

79 Thai Phien Don - CAND Phuoc Ninh - - Dong Nai Province - Vietnam

Percentage

 

2.632%

 

6. NAME

 

Mr. TRAN TUU

Date of Birth

 

06 Feb 1945

ID Number/Passport

 

020177307

Resident

 

61B Tu Xuong, Ward 7 - 3 District - Ho Chi Minh City - Vietnam

Nationality

 

Vietnamese

Percentage

 

2.632%

 

7. NAME

 

184 other shareholders

 

 

FINANCIAL DATA

 

BALANCE SHEET

Unit: One VND

Balance sheet date

31/12/2010

31/12/2009

31/12/2008

Number of weeks

52

52

52

ASSETS

A – CURRENT ASSETS

195,840,756,289

170,268,603,809

161,223,222,971

I. Cash and cash equivalents

18,174,025,946

12,303,402,797

7,114,166,721

1. Cash

18,174,025,946

12,303,402,797

7,114,166,721

2. Cash equivalents

0

0

0

II. Short-term investments

77,362,082,801

74,926,576,690

66,040,823,975

1. Short-term investments

77,362,082,801

74,926,576,690

66,040,823,975

2. Provisions for devaluation of short-term investments

0

0

0

III. Accounts receivable

60,040,943,731

44,038,847,729

36,515,264,457

1. Receivable from customers

58,624,361,503

41,489,421,872

36,075,656,734

2. Prepayments to suppliers

275,081,960

266,955,746

125,629,800

3. Inter-company receivable

0

0

0

4. Receivable according to the progress of construction

0

0

0

5. Other receivable

1,141,500,268

2,282,470,111

313,977,923

6. Provisions for bad debts

0

0

0

IV. Inventories

40,135,127,011

38,822,735,391

51,254,952,046

1. Inventories

40,135,127,011

38,822,735,391

51,254,952,046

2. Provisions for devaluation of inventories

0

0

0

V. Other Current Assets

128,576,800

177,041,202

298,015,772

1. Short-term prepaid expenses

0

0

0

2. VAT to be deducted

0

0

0

3. Taxes and other accounts receivable from the State

0

0

0

4. Other current assets

128,576,800

177,041,202

298,015,772

B. LONG-TERM ASSETS

1,407,813,231

1,737,709,503

1,107,853,125

I. Long term account receivable

0

0

0

1. Long term account receivable from customers

0

0

0

2. Working capital in affiliates

0

0

0

3. Long-term inter-company receivable

0

0

0

4. Other long-term receivable

0

0

0

5. Provisions for bad debts from customers

0

0

0

II. Fixed assets

1,351,571,512

1,088,144,346

344,413,938

1. Tangible assets

1,351,571,512

1,088,144,346

344,413,938

- Historical costs

3,094,964,526

2,599,562,699

1,867,132,227

- Accumulated depreciation

-1,743,393,014

-1,511,418,353

-1,522,718,289

2. Financial leasehold assets

0

0

0

- Historical costs

0

0

0

- Accumulated depreciation

0

0

0

3. Intangible assets

0

0

0

- Initial costs

0

0

0

- Accumulated amortization

0

0

0

4. Construction-in-progress

0

0

0

III. Investment property

0

0

0

Historical costs

0

0

0

Accumulated depreciation

0

0

0

IV. Long-term investments

0

0

0

1. Investments in affiliates

0

0

0

2. Investments in business concerns and joint ventures

0

0

0

3. Other long-term investments

0

0

0

4. Provisions for devaluation of long-term investments

0

0

0

V. Other long-term assets

56,241,719

649,565,157

763,439,187

1. Long-term prepaid expenses

56,241,719

649,565,157

763,439,187

2. Deferred income tax assets

0

0

0

3. Other long-term assets

0

0

0

TOTAL ASSETS

197,248,569,520

172,006,313,312

162,331,076,096

 

LIABILITIES

A- LIABILITIES

66,406,491,745

45,197,519,512

47,953,445,787

I. Current liabilities

64,270,031,666

43,061,059,433

45,816,985,708

1. Short-term debts and loans

0

0

0

2. Payable to suppliers

43,446,308,231

39,292,886,048

38,964,611,127

3. Advances from customers

12,789,743,853

827,310,055

5,993,445,104

4. Taxes and other obligations to the State Budget

2,829,293,250

2,940,863,330

417,165,707

5. Payable to employees

0

0

0

6. Accrued expenses

0

0

441,763,770

7. Inter-company payable

0

0

0

8. Payable according to the progress of construction contracts

0

0

0

9. Other payable

0

0

0

10. Provisions for short-term accounts payable

5,204,686,332

0

0

II. Long-Term Liabilities

2,136,460,079

2,136,460,079

2,136,460,079

1. Long-term accounts payable to suppliers

0

0

0

2. Long-term inter-company payable

0

0

0

3. Other long-term payable

0

0

0

4. Long-term debts and loans

2,136,460,079

2,136,460,079

2,136,460,079

5. Deferred income tax payable

0

0

0

6. Provisions for unemployment allowances

0

0

0

7. Provisions for long-term accounts payable

0

0

0

B- OWNER’S EQUITY

130,842,077,775

126,808,793,800

114,377,630,309

I. OWNER’S EQUITY

130,842,077,775

120,626,266,568

111,689,570,836

1. Capital

3,800,000,000

3,800,000,000

3,800,000,000

2. Share premiums

0

0

0

3. Other sources of capital

0

0

0

4. Treasury stocks

0

0

0

5. Differences on asset revaluation

0

0

0

6. Foreign exchange differences

0

0

0

7. Business promotion fund

103,050,038,057

90,429,410,630

90,609,410,630

8. Financial reserved fund

10,357,658,422

10,874,054,598

4,560,621,469

9. Other funds

0

52,173,913

0

10. Retained earnings

13,634,381,296

15,470,627,427

12,719,538,737

11. Construction investment fund

0

0

0

II. Other sources and funds

0

6,182,527,232

2,688,059,473

1. Bonus and welfare funds

0

6,182,527,232

2,688,059,473

2. Sources of expenditure

0

0

0

3. Fund to form fixed assets

0

0

0

MINORITY’S INTEREST

0

0

0

TOTAL LIABILITIES AND OWNER’S EQUITY

197,248,569,520

172,006,313,312

162,331,076,096

 


 

PROFIT & LOSS STATEMENT

 

Description

FY2010

FY2009

FY2008

1. Total Sale

421,126,402,157

347,187,508,589

321,784,720,394

2. Deduction item

442,819,020

98,354,430

271,039,627

3. Net sale

420,683,583,137

347,089,154,159

321,513,680,767

4. Costs of goods sold

395,232,637,142

323,143,488,295

303,928,922,462

5. Gross profit

25,450,945,995

23,945,665,864

17,584,758,305

6. Financial income

4,131,040,468

6,929,187,796

10,787,037,198

7. Financial expenses

2,101,275,113

3,037,911,512

2,032,904,866

- In which: Loan interest expenses

-

-

-

8. Selling expenses

0

0

0

9. Administrative overheads

9,338,431,098

9,277,475,410

9,003,774,380

10. Net operating profit

18,142,280,252

18,559,466,738

17,335,116,257

11. Other income

193,151,242

569,485,059

46,974,588

12. Other expenses

0

0

12,506,380

13. Other profit /(loss)

193,151,242

569,485,059

34,468,208

14. Total accounting profit before tax

18,335,431,494

19,128,951,797

17,369,584,465

15. Current corporate income tax

4,701,050,198

3,418,324,370

4,378,427,814

16. Deferred corporate income tax

0

0

0

18. Profit after tax

13,634,381,295

15,710,627,427

12,991,156,651

 

 

FINANCIAL RATIOS AND AVERAGE INDUSTRY RATIOS

 

Description

FY2010

FY2009

FY2008

Average Industry

Current liquidity ratio

3.05

3.95

3.52

2.19

Quick liquidity ratio

2.42

3.05

2.40

1.41

Inventory circle

9.85

8.32

5.93

4.67

Average receive period

52.09

46.31

41.45

79.16

Utilizing asset performance

2.13

2.02

1.98

1.91

Liability by total asset

33.67

26.28

29.54

56.82

Liability by owner equity

50.75

35.64

41.93

486.78

Ebit / Total asset (ROA)

9.30

11.12

10.70

10.47

Ebit / Owner's equity (ROE)

14.01

15.08

15.19

34.50

Ebit / Total sale (NPM)

4.35

5.51

5.40

6.80

Gross profit / Total sale (GPM)

6.04

6.90

5.46

20.29

Note: The Average Industry was calculated by Vietnam Credit based on our owned statistical data

 

 

 

PAYMENT HISTORY & PERFORMANCE EXPERIENCES

 

Trade Morality

 

Fair

Liquidity

 

High

Payment status

 

Above Average

Financial Situation

 

Above Average

Development trend

 

Even

Litigation data

 

No

Bankruptcy

 

No

Payment Methods

 

Directly to clients and through its network agents.

Sale Methods

 

Retailer and Wholesaler

 

 

 

 

INTERPRETATION ON THE SCORES

 

COMPANY OF PHARMACEUTICAL PRODUCTS OF VIETNAM was established in 1990. Currently, the subject is operating under business registration No. 059018 issued by Business Registration of Ho Chi Minh city with registered capital VND 3,800,000,000. The subject is the first joint stock pharmaceutical company in Hochiminh city, equitized in 1992.
The subject is specializing in importing and trading pharmaceutical products and medical equipment. The subject mainly imports products from France, Germany, Korea, Taiwan, China, America and England.
Besides head office located at No.126A, Tran Quoc Thao Str, Ward No.7, Dist. 3, Hochiminh City, the subject also has warehouse located at No.45A-45B Group 2- Phuoc Long B Ward, Dist No.9, Hochiminh City.

The operation of the subject is effective. The sale has been growing continuously. According to financial data, the subject’s business result in 2010 was better than in 2009 with the sale was 421 billion VND. The subject has got many good business partners. Its market share is large. The subject focuses most on the wholesale. According to interview with Ms. Ho Thi Ngoc Huong- Chief Accountant of the subject, business situation of the subject are stable and financial situation are fair good. Liquidity ratios of the subject are fair.
The subject’s position in the economy is fairly good. In opinion, the subject has capacity to meet the normal commitments.

 

APPENDIXES

 

INDUSTRY DATA

 

Industry code

Growth speed by price compared with 1994 (%)

Total enterprises 2009

Total employees 2010

(Thous.pers.)

Annual average capital of enterprises 2009

(billion dongs)

2010

2009

Agriculture, Forestry and Fishing

2.78

1.82

8,749

23,896.3

81,559

Industry and Construction

7.70

5.52

85,115

10,630

2,751,975

Trade and Services

7.52

6.63

154,978

14,522

4,939,069

 

ECONOMIC INDICATORS

 

 

2010 

2009 

2008 

Population (Million person)

86.93

86.02

86.1

Gross Domestic Products (US$ billion)

102.2

91

84.9

GDP Growth (%)

6.78

5.32

6.2

GDP Per Capita (US$)

1,160

1,080

1,040

Inflation (% Change in Composite CPI)

11.75

6.88

24.4

 

SERVICE TRADE PERFORMANCE

 

Billion USD 

2010 

2009 

2008 

Exports

72.2

57.1

62.7

Imports

84.8

69.9

80.7

Trade Balance

-12.6

-12.8

-18

Source: General Statistics Office


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.49.02

UK Pound

1

Rs.77.13

Euro

1

Rs.67.56

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.